Literature DB >> 19382040

[Usage of marginal organs for liver transplantation: a way around the critical organ shortage?].

S Pratschke1, F Loehe, C Graeb, K W Jauch, M K Angele.   

Abstract

The transplantation of marginal organs or those meeting the so-called extended donor criteria (EDC) is today a significant option to alleviate the low availability or organs and to increase the number of transplantation which in turn is -accompanied by a lower mortality among wait-ing-list patients. However such an extension of the spender pool carries the risks of an increased incidence of organ dysfuntions and a higher recipient mortality. This situation presents an ethical problem when marginal organs are accepted for transplantation because the anticipated mortality for the individual recipient cannot be determined. The transplantation of marginal organs from -donors with a high MELD score seems to be linked to a higher mortality. In particular, the combina-tions of high donor age and long ischaemic time or advanced donor age and hepatitis C infection in the recipient are definitively associated with a significantly poorer organ survival rate. In view of the serious lack of organs, efforts should be made, for example, by shortening of the is-chae-mic time and the development of therapeutic strategies, to improve the function and increase the number of usable marginal organs and thus to increase pool of donor organs. The refusal of marginal organs on the basis of individual EDC without consideration of the status of recipient does not seem to be adequate.

Entities:  

Mesh:

Year:  2009        PMID: 19382040     DOI: 10.1055/s-0028-1098880

Source DB:  PubMed          Journal:  Zentralbl Chir        ISSN: 0044-409X            Impact factor:   0.942


  4 in total

Review 1.  [Challenges in the organization of investigator initiated trials: in transplantation medicine].

Authors:  A A Schnitzbauer; P E Lamby; I Mutzbauer; J von Hassel; E K Geissler; H J Schlitt
Journal:  Chirurg       Date:  2011-03       Impact factor: 0.955

2.  Impact of combined ischemic preconditioning and remote ischemic perconditioning on ischemia-reperfusion injury after liver transplantation.

Authors:  Ding-Yang Li; Wen-Tao Liu; Guang-Yi Wang; Xiao-Ju Shi
Journal:  Sci Rep       Date:  2018-12-19       Impact factor: 4.379

3.  Protocol TOP-Study (tacrolimus organ perfusion): a prospective randomized multicenter trial to reduce ischemia reperfusion injury in transplantation of marginal liver grafts with an ex vivo tacrolimus perfusion.

Authors:  Sebastian Pratschke; Michael Eder; Michael Heise; Silvio Nadalin; Andreas Pascher; Peter Schemmer; Marcus N Scherer; Frank Ulrich; Heiner Wolters; Karl-Walter Jauch; Dirk Wöhling; Martin K Angele
Journal:  Transplant Res       Date:  2013-03-04

4.  Results of the TOP Study: Prospectively Randomized Multicenter Trial of an Ex Vivo Tacrolimus Rinse Before Transplantation in EDC Livers.

Authors:  Sebastian Pratschke; Hannah Arnold; Alfred Zollner; Michael Heise; Andreas Pascher; Peter Schemmer; Marcus N Scherer; Andreas Bauer; Karl-Walter Jauch; Jens Werner; Markus Guba; Martin K Angele
Journal:  Transplant Direct       Date:  2016-05-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.